The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty

• Published in: Annals of clinical biochemistry Vol. 41; no. 2; pp. 142 - 148
• Main Authors: Elsman, Peter, Zijlstra, Felix, Miedema, Kor, Hoorntje, Jan C A, Dikkeschei, Lambert D, Slingerland, Robbert J, Reiffers, Stoffer, de Boer, Menko-Jan, Suryapranata, Harry
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.03.2004; Sage Publications Ltd
• Subjects: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Female; Humans; L-Lactate Dehydrogenase - blood; Male; Middle Aged; Myocardial Infarction - blood; Myocardial Infarction - pathology; Myocardial Infarction - therapy; Predictive Value of Tests; Risk Factors; Time Factors
• ISSN: 0004-5632; 1758-1001
• DOI: 10.1258/000456304322880041

Background: In patients with acute myocardial infarction, estimation of infarct size by cumulative lactate dehydrogenase release at 72 h (LDHQ72) is a simple and widely used method. Our objective was to study the value of estimating infarct size, by the cumulative release of LDH over 72, 60, 48 and 36 h in predicting left ventricular ejection fraction (LVef) and cardiac death at 1 year. Methods: In the Zwolle Infarction Study infarct size estimated as LDHQ was calculated in 1224 patients treated with primary percutaneous coronary intervention for acute myocardial infarction between December 1993 and June 2001. Patients were categorized as having small (LDHQ72<800 U/L), medium (LDHQ72 800-2500 U/L) or large (LDHQ72>2500 U/L) myocardial infarction. Results: LDHQ72 was closely correlated with LDHQ60, LDHQ48 and LDHQ36 (r = 0.998, 0.993 and 0.987, respectively, P <0.0001). The relations between LDHQ infarct size classification and mean LVef (51% vs 45% vs 35%, P <0.001) or cardiac death at 1 year (0-0.3% vs 0.7-1% vs 6-8%) showed a similar pattern, irrespective of whether LDH was measured up to 36, 48, 60 or 72 h. Conclusion: Infarct size classification based on LDHQ36 is an objective and widely available method for early risk stratification in patients treated with primary angioplasty for acute ST-segment elevation myocardial infarction.